Literature DB >> 2962196

Activation of resting human B cells by helper T-cell clone supernatant: characterization of a human B-cell-activating factor.

A Diu1, M L Gougeon, J L Moreau, E L Reinherz, J Thèze.   

Abstract

The effects of helper T-cell clone supernatants on resting human B cells were investigated. Four different helper T-cell clones (two T4+ and two T8+) were stimulated by anti-T3 monoclonal antibodies on Sepharose beads or anti-T11(2) plus anti-T11(3) monoclonal antibodies. The supernatants from these activated clones induced the proliferation of highly purified resting B lymphocytes from the peripheral blood. The B cells exhibited a cell size and a surface-antigen pattern (4F2 antigen and transferrin receptor) of phase G0 B cells, and they were functionally resting. In response to T-cell supernatants a large fraction of the B cells enlarged and expressed 4F2 antigens and transferrin receptors. In gel filtration, the corresponding activity migrated with an apparent Mr of 12,000-15,000. Our findings strongly support the existence of a human B-cell-activating factor acting on resting B cells and causing them to enter phase G1 of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2962196      PMCID: PMC299708          DOI: 10.1073/pnas.84.24.9140

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Anti-interleukin 2 receptor monoclonal antibodies. Respective role of epitope mapping and monoclonal antibody-receptor interactions in their antagonist effects on interleukin 2-dependent T cell growth.

Authors:  D Olive; J Raymond; P Dubreuil; D Charmot; Y Jacques; C Mawas
Journal:  Eur J Immunol       Date:  1986-06       Impact factor: 5.532

2.  Supernatant from a cloned helper T cell stimulates resting B cells to express transferrin and IL-2 receptors.

Authors:  A Diu; L Leclercq; A Dautry-Varsat; J Theze
Journal:  Cell Immunol       Date:  1987-07       Impact factor: 4.868

3.  Characterization of a human B lymphocyte-specific antigen.

Authors:  P Stashenko; L M Nadler; R Hardy; S F Schlossman
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

4.  An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein.

Authors:  S C Meuer; R E Hussey; M Fabbi; D Fox; O Acuto; K A Fitzgerald; J C Hodgdon; J P Protentis; S F Schlossman; E L Reinherz
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

5.  Differential expression of cell activation markers after stimulation of resting human B lymphocytes.

Authors:  J H Kehrl; A Muraguchi; A S Fauci
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

6.  Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities.

Authors:  T Yokota; T Otsuka; T Mosmann; J Banchereau; T DeFrance; D Blanchard; J E De Vries; F Lee; K Arai
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

7.  Human B cell differentiation. IV. Effect of monoclonal anti-immunoglobulin M and D antibodies on B cell proliferation and differentiation induced by T cell factors.

Authors:  T Kuritani; M D Cooper
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

8.  Antigens on human monocytes identified by monoclonal antibodies.

Authors:  R F Todd; L M Nadler; S F Schlossman
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

9.  Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics.

Authors:  K A Smith; M F Favata; S Oroszlan
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

10.  Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones.

Authors:  S C Meuer; J C Hodgdon; R E Hussey; J P Protentis; S F Schlossman; E L Reinherz
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  2 in total

1.  Activation of genetically major histocompatibility complex (MHC) class II-deficient B lymphocytes.

Authors:  A Durandy; M Mangeney; C Griscelli; M Forveille; F Le Deist; A Fischer
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

2.  Hyper-IgM immunodeficiency syndrome: influence of lymphokines on in vitro maturation of peripheral B cells.

Authors:  M L Gougeon; L Morelet; M Doussau; J Theze; C Griscelli; A Fischer
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.